Home



ZADAXIN
(thymosin alpha 1)



ZADAXIN
Bibliography &
Presentations



Medical
Conferences



Contact



Site Map



International
Language Support
   

Product Monograph

Table of Contents		  

List of Tables and Figures
List of Abbreviations
Introduction
Chemical Properties of Zadaxin (thymalfasin)
Mechanism of Action of Zadaxin
Use of Zadaxin in Disease States
Animal Models
• Woodchuck Hepatitis
• Other Animal Models of Infection
• Animal Models of Cancer
Hepatitis B
• Hepatitis B Treatment Options
• Zadaxin Monotherapy in Hepatitis B
• Zadaxin Plus IFNα Combination Therapy for Chronic Hepatitis B
• Zadaxin Plus Nucleoside Analogues Combination Treatment for Chronic Hepatitis B
• Key Takeaways
Hepatitis C
• Clinical Trials
• Zadaxin Plus IFNα Combination Therapy for Chronic Hepatitis C
• US hepatitis C trial
• Italian Hepatitis C trial and Thailand Hepatitis C trial, Interim Results
• Summary and Key Takeaways

Human Immunodeficiency Virus
Vaccine Adjuvant in Immunocompromised Patients
• Introduction
• Cornell Medical Center (Ithaca, New York) and University of Wisconsin trials
• George Washington University trial
• Hemodialysis Patients
• Key Takeaways
Cancer
• Introduction
• Hepatocellular Carcinoma
• Non–Small-Cell Lung Cancer
• Malignant Melanoma
• Key Takeaways
Toxicity and Safety
Toxicity in Animals and in Vitro
Safety in Humans
Human Pharmacokinetics
References
 




 


  Home | Zadaxin | Scientific Papers | Conferences | Contact | Site Map
Copyright © 2003-2004 SciClone Pharmaceuticals International